DBS of the PSA and the VIM in essential tremor A randomized, double-blind, crossover trial

被引:110
|
作者
Barbe, Michael T. [1 ]
Reker, Paul [1 ]
Hamacher, Stefanie [3 ]
Franklin, Jeremy [3 ]
Kraus, Daria [4 ]
Dembek, Till A. [1 ,2 ]
Becker, Johannes [1 ]
Steffen, Julia K. [1 ]
Allert, Niels [5 ]
Wirths, Jochen [2 ]
Dafsari, Haidar S. [1 ,6 ]
Voges, Juergen [7 ]
Fink, Gereon R. [1 ,8 ]
Visser-Vandewalle, Veerle [2 ]
Timmermann, Lars [1 ,9 ]
机构
[1] Univ Hosp Cologne, Dept Neurol, Cologne, Germany
[2] Univ Hosp Cologne, Dept Stereotaxy & Funct Neurosurg, Cologne, Germany
[3] Univ Cologne, Inst Med Stat & Computat Biol, Cologne, Germany
[4] Univ Cologne, Clin Trials Ctr Cologne, Cologne, Germany
[5] Neurol Rehabil Ctr Godeshohe, Bonn, Germany
[6] Kings Coll Hosp London, Natl Parkinson Fdn, Int Ctr Excellence, London, England
[7] Otto von Guericke Univ, Dept Stereotact Neurosurg, Magdeburg, Germany
[8] Res Ctr Julich, Leibniz Inst Neurobiol, Cognit Neurosci, Inst Neurosci & Med INM 3, Julich, Germany
[9] Univ Hosp Marburg, Dept Neurol, Marburg, Germany
关键词
DEEP BRAIN-STIMULATION; POSTERIOR SUBTHALAMIC AREA; THALAMIC-STIMULATION; INTENTION TREMOR; RATING-SCALE; NUCLEUS; NEUROSTIMULATION; COMPLICATIONS; QUESTIONNAIRE; ELECTRODE;
D O I
10.1212/WNL.0000000000005956
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective To evaluate deep brain stimulation (DBS) of the posterior subthalamic area (PSA) in essential tremor (ET) and compare it to the ventral intermediate nucleus of the thalamus (VIM) in terms of stimulation efficacy, efficiency, and side effects. Methods DBS leads were implanted such that contacts were placed in the VIM, on the intercommissural line, and in the PSA. Thirteen patients with ET entered a randomized, double-blind crossover phase and completed a 1-year follow-up. Results PSA-DBS significantly reduced tremor severity and improved quality of life. There were no relevant differences in quality and frequency of stimulation side effects between VIM and PSA, with a tendency toward greater tremor improvement with PSA stimulation. Clinical benefit was achieved at significantly lower stimulation amplitudes in the PSA. The majority of patients remained with PSA-DBS after 1 year. Conclusion In accordance with previous retrospective investigations, our prospective data suggest that PSA-DBS is at least equally effective as but possibly more efficient than VIM-DBS. Classification of evidence This study provides Class I evidence that for patients with essential tremor, PSA-DBS is not significantly different from VIM-DBS in suppressing tremor, but clinical benefit from PSA-DBS is attained at lower stimulation amplitudes.
引用
收藏
页码:E543 / E550
页数:8
相关论文
共 50 条
  • [1] Editors' note: DBS of the PSA and the VIM in essential tremor: A randomized, double-blind, crossover trial
    Lewis, Ariane
    Galetta, Steven
    NEUROLOGY, 2019, 92 (20) : 974 - 974
  • [2] Author response: DBS of the PSA and the VIM in essential tremor: A randomized, double-blind, crossover trial
    Barbe, Michael T.
    Reker, Paul
    Hamacher, Stefanie
    Franklin, Jeremy
    Kraus, Daria
    Dembek, Till A.
    Becker, Johannes
    Steffen, Julia K.
    Allert, Niels
    Wirths, Jochen
    Dafsari, Haidar S.
    Voges, Juergen
    Fink, Gereon R.
    Visser-Vandewalle, Veerle
    Timmermann, Lars
    NEUROLOGY, 2019, 92 (20) : 975 - 976
  • [3] A Double-blind, Randomized, Crossover Clinical Trial comparing VIM vs. PSA Deep Brain Stimulation for Disabling Essential Tremor
    Triguero-Cueva, L.
    Madrid Navarro, C. J.
    Perez Navarro, M. J.
    Ianez Velasco, B.
    Martinez Barbero, J. P.
    Marin-Romero, B.
    Minguez-Castellanos, A.
    Escamilla-Sevilla, F.
    Jouma Katati, M.
    MOVEMENT DISORDERS, 2024, 39 : S519 - S519
  • [4] Double-blind, Randomized, Crossover Clinical Trial to Compare VIM Vs PSA Deep Brain Stimulation In Patients with Disabling Essential Tremor. Preliminary Results
    Triguero-Cueva, L.
    Madrid Navarro, C. J.
    Perez Navarro, M. J.
    Ianez Velasco, B.
    Jouma Katati, M.
    Martinez Barbero, J. P.
    Minguez-Castellanos, A.
    Escamilla Sevilla, F.
    MOVEMENT DISORDERS, 2023, 38 : S739 - S739
  • [5] Technical Issues of Vim-PSA Double-Target DBS for Essential Tremor
    Hou, Xusheng
    Mo, Yixiang
    Zhu, Zhiyuan
    Zhang, Huan
    Liu, Xinzi
    Zou, Zhihao
    He, Xiaozheng
    Xue, Shan
    Li, Jiangtao
    Li, Mengqian
    Zhang, Shizhong
    BRAIN SCIENCES, 2023, 13 (04)
  • [6] A double-blind placebo controlled crossover trial of topiramate in essential tremor
    Frima, N
    Grünewald, RA
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76 (01): : 157 - 157
  • [7] A Pilot Double-Blind Randomized Trial of Perampanel for Essential Tremor
    Handforth, Adrian
    Tse, Winona
    Elble, Rodger J.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2020, 7 (04): : 399 - 404
  • [8] Efficacy and tolerability of pregabalin in essential tremor: A randomized, double-blind, placebo-controlled, crossover trial
    Ferrara, Joseph M.
    Kenney, Christopher
    Davidson, Anthony L.
    Shinawi, Lina
    Kissel, Abigail M.
    Jankovic, Joseph
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 (1-2) : 195 - 197
  • [9] Olanzapine in essential tremor: A double-blind, crossover, placebo-controlled trial
    Entner, T
    Wissel, J
    Mueller, J
    Seppi, K
    Wenning, GK
    Poewe, W
    MOVEMENT DISORDERS, 2002, 17 : S350 - S350
  • [10] A double-blind, placebo-controlled, crossover trial of topiramate in essential tremor
    Frima, N
    Grünewald, RA
    CLINICAL NEUROPHARMACOLOGY, 2006, 29 (02) : 94 - 96